132 related articles for article (PubMed ID: 22223845)
41. Increased visceral fat mass and insulin signaling in colitis-related colon carcinogenesis model mice.
Miyamoto S; Tanaka T; Murakami A
Chem Biol Interact; 2010 Jan; 183(2):271-5. PubMed ID: 19931517
[TBL] [Abstract][Full Text] [Related]
42. Canola oil influence on azoxymethane-induced colon carcinogenesis, hypertriglyceridemia and hyperglycemia in Kunming mice.
He XQ; Cichello SA; Duan JL; Zhou J
Asian Pac J Cancer Prev; 2014; 15(6):2477-83. PubMed ID: 24761850
[TBL] [Abstract][Full Text] [Related]
43. Tumor formation is correlated with expression of beta-catenin-accumulated crypts in azoxymethane-induced colon carcinogenesis in mice.
Hata K; Yamada Y; Kuno T; Hirose Y; Hara A; Qiang SH; Mori H
Cancer Sci; 2004 Apr; 95(4):316-20. PubMed ID: 15072589
[TBL] [Abstract][Full Text] [Related]
44. Effects of diet-induced obesity on colitis-associated colon tumor formation in A/J mice.
Park SY; Kim JS; Seo YR; Sung MK
Int J Obes (Lond); 2012 Feb; 36(2):273-80. PubMed ID: 21544082
[TBL] [Abstract][Full Text] [Related]
45. Elevated circulating adiponectin and elevated insulin sensitivity in adiponectin transgenic mice are not associated with reduced susceptibility to colon carcinogenesis.
Ealey KN; Archer MC
Int J Cancer; 2009 May; 124(9):2226-30. PubMed ID: 19123482
[TBL] [Abstract][Full Text] [Related]
46. Genome-wide association and fine mapping of genetic loci predisposing to colon carcinogenesis in mice.
Liu P; Lu Y; Liu H; Wen W; Jia D; Wang Y; You M
Mol Cancer Res; 2012 Jan; 10(1):66-74. PubMed ID: 22127497
[TBL] [Abstract][Full Text] [Related]
47. High susceptibility to azoxymethane-induced colorectal carcinogenesis in obese KK-Ay mice.
Teraoka N; Mutoh M; Takasu S; Ueno T; Nakano K; Takahashi M; Imai T; Masuda S; Sugimura T; Wakabayashi K
Int J Cancer; 2011 Aug; 129(3):528-35. PubMed ID: 20886595
[TBL] [Abstract][Full Text] [Related]
48. Ay allele promotes azoxymethane-induced colorectal carcinogenesis by macrophage migration in hyperlipidemic/diabetic KK mice.
Ito K; Ishigamori R; Mutoh M; Ohta T; Imai T; Takahashi M
Cancer Sci; 2013 Jul; 104(7):835-43. PubMed ID: 23551905
[TBL] [Abstract][Full Text] [Related]
49. Risk of colonic cancer is not higher in the obese Lep(ob) mouse model compared to lean littermates.
Sikalidis AK; Fitch MD; Fleming SE
Pathol Oncol Res; 2013 Oct; 19(4):867-74. PubMed ID: 23813464
[TBL] [Abstract][Full Text] [Related]
50. Pitavastatin inhibits azoxymethane-induced colonic preneoplastic lesions in C57BL/KsJ-db/db obese mice.
Yasuda Y; Shimizu M; Shirakami Y; Sakai H; Kubota M; Hata K; Hirose Y; Tsurumi H; Tanaka T; Moriwaki H
Cancer Sci; 2010 Jul; 101(7):1701-7. PubMed ID: 20398056
[TBL] [Abstract][Full Text] [Related]
51. Activins and their related proteins in colon carcinogenesis: insights from early and advanced azoxymethane rat models of colon cancer.
Refaat B; El-Shemi AG; Mohamed AM; Kensara OA; Ahmad J; Idris S
BMC Cancer; 2016 Nov; 16(1):879. PubMed ID: 27835986
[TBL] [Abstract][Full Text] [Related]
52. Oral Administration of Microencapsulated
Valadez-Bustos N; Escamilla-Silva EM; García-Vázquez FJ; Gallegos-Corona MA; Amaya-Llano SL; Ramos-Gómez M
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31480481
[TBL] [Abstract][Full Text] [Related]
53. A mixture of Persistent Organic Pollutants (POPs) and Azoxymethane (AOM) show potential synergistic effects on intestinal tumorigenesis in the A/J Min/+ mouse model.
Hansen KEA; Johanson SM; Steppeler C; Sødring M; Østby GC; Berntsen HF; Zimmer KE; Aleksandersen M; Paulsen JE; Ropstad E
Chemosphere; 2019 Jan; 214():534-542. PubMed ID: 30278405
[TBL] [Abstract][Full Text] [Related]
54. Hemizygous mice for the angiotensin II type 2 receptor gene have attenuated susceptibility to azoxymethane-induced colon tumorigenesis.
Takagi T; Nakano Y; Takekoshi S; Inagami T; Tamura M
Carcinogenesis; 2002 Jul; 23(7):1235-41. PubMed ID: 12117783
[TBL] [Abstract][Full Text] [Related]
55. Neonatal monosodium glutamate treatment causes obesity, diabetes, and macrovesicular steatohepatitis with liver nodules in DIAR mice.
Tsuneyama K; Nishida T; Baba H; Taira S; Fujimoto M; Nomoto K; Hayashi S; Miwa S; Nakajima T; Sutoh M; Oda E; Hokao R; Imura J
J Gastroenterol Hepatol; 2014 Sep; 29(9):1736-43. PubMed ID: 24730643
[TBL] [Abstract][Full Text] [Related]
56. Early increase in blood supply (EIBS) is associated with tumor risk in the Azoxymethane model of colon cancer.
Ruderman S; Eshein A; Valuckaite V; Dougherty U; Almoghrabi A; Gomes A; Singh A; Pabla B; Roy HK; Hart J; Bissonnette M; Konda V; Backman V
BMC Cancer; 2018 Aug; 18(1):814. PubMed ID: 30103733
[TBL] [Abstract][Full Text] [Related]
57. Weight loss following diet-induced obesity does not alter colon tumorigenesis in the AOM mouse model.
Velázquez KT; Enos RT; Carson MS; Cranford TL; Bader JE; Chatzistamou I; Singh UP; Nagarkatti PS; Nagarkatti M; Davis JM; Carson JA; Murphy EA
Am J Physiol Gastrointest Liver Physiol; 2016 Oct; 311(4):G699-G712. PubMed ID: 27609769
[TBL] [Abstract][Full Text] [Related]
58. Deletion of functional gastrin gene markedly increases colon carcinogenesis in response to azoxymethane in mice.
Cobb S; Wood T; Tessarollo L; Velasco M; Given R; Varro A; Tarasova N; Singh P
Gastroenterology; 2002 Aug; 123(2):516-30. PubMed ID: 12145805
[TBL] [Abstract][Full Text] [Related]
59. Susceptibility of Snark-deficient mice to azoxymethane-induced colorectal tumorigenesis and the formation of aberrant crypt foci.
Tsuchihara K; Ogura T; Fujioka R; Fujii S; Kuga W; Saito M; Ochiya T; Ochiai A; Esumi H
Cancer Sci; 2008 Apr; 99(4):677-82. PubMed ID: 18307533
[TBL] [Abstract][Full Text] [Related]
60. Mice overexpressing progastrin are predisposed for developing aberrant colonic crypt foci in response to AOM.
Singh P; Velasco M; Given R; Wargovich M; Varro A; Wang TC
Am J Physiol Gastrointest Liver Physiol; 2000 Mar; 278(3):G390-9. PubMed ID: 10712258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
